About Encellin
Encellin is a company based in San Francisco (United States) founded in 2015 by Crystal Nyitray.. Encellin has raised $18.45 million across 4 funding rounds from investors including Khosla Ventures, Y Combinator and SV Latam Capital. Encellin offers products and services including ENCRT. Encellin operates in a competitive market with competitors including Organogenesis, Sofregen, BioTissue, Reapplix and Acera Surgical, among others.
- Headquarter San Francisco, United States
- Founders Crystal Nyitray
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.45 M (USD)
in 4 rounds
-
Latest Funding Round
$9.94 M (USD), Series A
Sep 20, 2023
-
Investors
Khosla Ventures
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Encellin
Encellin offers a comprehensive portfolio of products and services, including ENCRT. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Implant that encapsulates cells to deliver therapeutics for chronic diseases.
Unlock access to complete
Unlock access to complete
Funding Insights of Encellin
Encellin has successfully raised a total of $18.45M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $9.94 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $9.9M
-
First Round
First Round
(19 Jul 2019)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series A - Encellin | Valuation | Khosla Ventures | |
| Aug, 2021 | Amount | Seed - Encellin | Valuation | Khosla Ventures , SV Latam Capital | |
| Aug, 2019 | Amount | Seed - Encellin | Valuation | Y Combinator |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Encellin
Encellin has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Y Combinator and SV Latam Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in science and technology startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Encellin
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Encellin
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Encellin Comparisons
Competitors of Encellin
Encellin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Organogenesis, Sofregen, BioTissue, Reapplix and Acera Surgical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative therapies for wound care are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| domain | founded_year | HQ Location |
Regenerative biologic therapies for eye care are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of patch system for wound healing
|
|
| domain | founded_year | HQ Location |
Synthetic electrospun scaffolds are provided for regenerative medical uses.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Encellin
Frequently Asked Questions about Encellin
When was Encellin founded?
Encellin was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Where is Encellin located?
Encellin is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Encellin?
Crystal Nyitray is the current CEO of Encellin. They have also founded this company.
Is Encellin a funded company?
Encellin is a funded company, having raised a total of $18.45M across 4 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Jul 19, 2019.
What does Encellin do?
Encellin is developing regenerative materials using cell transplant therapy. The company has developed cell transplant therapy for treating missing, damaged, or diseased cells and treatment of chronic diseases.
Who are the top competitors of Encellin?
Encellin's top competitors include Organogenesis, GeniPhys and Acera Surgical.
What products or services does Encellin offer?
Encellin offers ENCRT.
Who are Encellin's investors?
Encellin has 4 investors. Key investors include Khosla Ventures, Y Combinator, SV Latam Capital, and Sand Hill Angels.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.